Literature DB >> 8601607

Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.

J T Vilquin1, I Kinoshita, B Roy, M Goulet, E Engvall, F Tomé, M Fardeau, J P Tremblay.   

Abstract

Laminin-2 is a component of skeletal and cardiac basal lamina expressed in normal mouse and human. Laminin alpha2 chain (LAMA2), however, is absent from muscles of some congenital muscular dystrophy patients and the dystrophia muscularis (dy/dy) mouse model. LAMA2 restoration was investigated following cell transplantation in vivo in dy/dy mouse. Allogeneic primary muscle cell cultures expressing the beta-galactosidase transgene under control of a muscular promoter, or histocompatible primary muscle cell cultures, were transplanted into dy/dy mouse muscles. FK506 immunosuppression was used in noncompatible models. All transplanted animals expressed LAMA2 in these immunologically-controlled models, and the degrees of LAMA2 restoration were shown to depend on the age of the animal at transplantation, on muscle pretreatment, and on duration time after transplantation in some cases. LAMA2 did not always colocalize with new or hybrid muscle fibers formed by the fusion of donor myoblasts. LAMA2 deposition around muscle fibers was often segmental and seemed to radiate from the center to the periphery of the injection site. Allogeneic conditionally immortalized pure myogenic cells expressing the beta-galactosidase transgene were characterized in vitro and in vivo. When injected into FK506-immunosuppressed dy/dy mice, these cells formed new or hybrid muscle fibers but essentially did not express LAMA2 in vivo. These data show that partial LAMA2 restoration is achieved in LAMA2-deficient dy/dy mouse by primary muscle cell culture transplantation. However, not all myoblasts, or myoblasts alone, or the muscle fibers they form are capable of LAMA2 secretion and deposition in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601607      PMCID: PMC2120785          DOI: 10.1083/jcb.133.1.185

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  52 in total

1.  Merosin, a tissue-specific basement membrane protein, is a laminin-like protein.

Authors:  K Ehrig; I Leivo; W S Argraves; E Ruoslahti; E Engvall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

2.  Abnormal localization of laminin subunits in muscular dystrophies.

Authors:  Y K Hayashi; E Engvall; E Arikawa-Hirasawa; K Goto; R Koga; I Nonaka; H Sugita; K Arahata
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

3.  A new nomenclature for the laminins.

Authors:  R E Burgeson; M Chiquet; R Deutzmann; P Ekblom; J Engel; H Kleinman; G R Martin; G Meneguzzi; M Paulsson; J Sanes
Journal:  Matrix Biol       Date:  1994-04       Impact factor: 11.583

4.  Successful myoblast allotransplantation in mdx mice using rapamycin.

Authors:  J T Vilquin; I Asselin; B Guérette; I Kinoshita; R Roy; J P Tremblay
Journal:  Transplantation       Date:  1995-02-15       Impact factor: 4.939

5.  Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene.

Authors:  H Xu; X R Wu; U M Wewer; E Engvall
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

6.  Long term survival of allografted muscle precursor cells following a limited period of treatment with cyclosporin A.

Authors:  D J Watt; J E Morgan; T A Partridge
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

7.  Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle.

Authors:  J Philpot; C Sewry; J Pennock; V Dubowitz
Journal:  Neuromuscul Disord       Date:  1995-07       Impact factor: 4.296

8.  High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.

Authors:  J Huard; S Verreault; R Roy; M Tremblay; J P Tremblay
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD.

Authors:  S Wakeford; D J Watt; T A Partridge
Journal:  Muscle Nerve       Date:  1991-01       Impact factor: 3.217

10.  Complex fiber-type-specific expression of fast skeletal muscle troponin I gene constructs in transgenic mice.

Authors:  P L Hallauer; H L Bradshaw; K E Hastings
Journal:  Development       Date:  1993-11       Impact factor: 6.868

View more
  6 in total

Review 1.  Influence of exercise and aging on extracellular matrix composition in the skeletal muscle stem cell niche.

Authors:  Koyal Garg; Marni D Boppart
Journal:  J Appl Physiol (1985)       Date:  2016-08-18

Review 2.  Stem cell therapy for muscular dystrophies.

Authors:  Stefano Biressi; Antonio Filareto; Thomas A Rando
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  Plasmonic fusion between fibroblasts and skeletal muscle cells for skeletal muscle regeneration.

Authors:  Limor Minai; Dvir Yelin
Journal:  Biomed Opt Express       Date:  2022-01-06       Impact factor: 3.732

4.  Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source.

Authors:  J R Beauchamp; J E Morgan; C N Pagel; T A Partridge
Journal:  J Cell Biol       Date:  1999-03-22       Impact factor: 10.539

Review 5.  A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD.

Authors:  Kinga I Gawlik; Madeleine Durbeej
Journal:  Front Mol Neurosci       Date:  2020-04-21       Impact factor: 5.639

Review 6.  Muscular dystrophies.

Authors:  Monisha Mukherjee; Balraj Mittal
Journal:  Indian J Pediatr       Date:  2004-02       Impact factor: 5.319

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.